Bonspri 20mg Injection
Bonspri 20 mg (Ofatumumab) Injection is a monoclonal antibody indicated for the treatment of relapsing forms of multiple sclerosis (MS) in adults. It targets CD20-positive B cells, helping reduce disease activity, lower relapse rates, and slow disability progression. Bonspri is administered as a subcutaneous injection under the supervision of a qualified healthcare professional. This prescription medicine should be used only as directed by a physician.
| Brand | Bonspri |
| Storage Temperature | 2°C to 8°C (Refrigerated) |
| Dosage | As prescribed by the physician |
| Prescription Needed | Yes |
| Composition | Ofatumumab |
| Strength | 20 mg |
| Form | Injection |
| Pack Size | 1 Syringe |
| Packaging | 1 Prefilled Syringe |
| Country of Origin | India |
| Manufacturer | Novartis |
Bonspri 20mg Injection
Bonspri 20 mg (Ofatumumab) Injection is a monoclonal antibody indicated for the treatment of relapsing forms of multiple sclerosis (MS) in adults. It targets CD20-positive B cells, helping reduce disease activity, lower relapse rates, and slow disability progression. Bonspri is administered as a subcutaneous injection under the supervision of a qualified healthcare professional. This prescription medicine should be used only as directed by a physician.